Intravitreal injection of perfluoropropane for the treatment of vitreomacular traction

Clicks: 381
ID: 53050
2013
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #9 of 48 articles by views in guoji yanke zazhi

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
AIM: To study the efficacy of a single intravitreal injection of perfluoropropane(C3F8)in releasing vitreomacular traction.

METHODS: Twelve eyes of 12 consecutive patients with vitreomacular traction received a single intravitreal injection of 0.3mL 100%(C3F8)were retrospectively analyzed. The best corrected vision acuity and the neural epithelium thickness of central macular were observed.

RESULTS: One month following treatment, vitreomacular traction was released in 5 eyes(42%), mean final visual acuity(VA)improved 0.04 and mean central foveal thickness decreased by 69μm. The vision acuity before and after treatment were 0.20±0.07, 0.25±0.04 respectively.

CONCLUSION: Intravitreal C3F8 injection could offer a minimally invasive alternative to pars plana vitrectomy in patients with vitreomacular traction.

Reference Key
wan2013intravitrealguoji Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Wan, Xiao-Ping;Feng, Chao;Chen, Chang-Zheng;Wang, Yong-Song;
Journal guoji yanke zazhi
Year 2013
DOI
DOI not found
URL
http://www.ies.net.cn/cn_publish/2013/7/201307058.pdf
Keywords
ophthalmology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.